Miglustat does not impact clinical progression in patients with spastic paraplegia type 11. - Mero S; Ricca I; Rossi S; Mellone S; Musumeci O; Zanna GD; Michelucci E; Bagnoli S; Nacmias B; Tessa A; Rocchiccioli S; Silvestri G; et al. (Neurogenetics, 2025)